UiPath Analysts Boost Their Forecasts Following Upbeat Q2 Results

UiPath Inc (NYSE: PATH) reported better-than-expected second-quarter results.

UiPath Inc (NYSE:PATH) reported better-than-expected second-quarter results.

UiPath posted quarterly earnings of nine cents per share which beat the analyst consensus estimate of three cents, a 550% increase over losses of two cents per share from the same period last year. The company reported quarterly sales of $287.00 million which beat the analyst consensus estimate of $282.14 million, an 18.49% increase over sales of $242.22 million in the same period last year.

UiPath said it sees third-quarter revenue to be between $313 million and $318 million, versus the $315.33 million estimate. Full-year 2024 revenue is anticipated to be between $1.273 billion and $1.278 billion, versus the $1.27 billion estimate.

UiPath shares gained 2% to $16.55 in pre-market trading.

These analysts made changes to their price targets on UiPath following earnings announcement.

  • RBC Capital increased the price target on UiPath from $18 to $19. RBC Capital analyst Matthew Hedberg maintained a Sector Perform rating.
  • BMO Capital boosted the price target on UiPath from $18 to $19. BMO Capital analyst Keith Bachman maintained a Market Perform rating.
  • Needham analyst Scott Berg, meanwhile, reiterated UiPath with a Buy and maintained a $20 price target.

Read This Next: SAIC, GameStop And 3 Stocks To Watch Heading Into Thursday

Total
0
Shares
Related Posts
Read More

US Healthcare Landlord Medical Properties Trust’s Largest Tenant Steward Health Goes Bankrupt, Sparks Regulatory Concerns

Amid Chapter 11 bankruptcy, Steward Health Care, Medical Properties Trust's tenant, faces financial turmoil. State regulators scrutinize its 30 hospitals, grappling with incidents like bat evacuations, unpaid nurses, and equipment shortages. Steward's reliance on MPW for a $300 million loan raises eyebrows, as stakeholders navigate complex ties amid regulatory interventions.

MPW